In a follow-up analysis, ELOVL7’s role in altering lipid profiles and its connection to de novo androgen synthesis were further elucidated, indicating that ELOVL7 could be a pivotal target for therapeutic strategies aimed at mitigating prostate cancer progression via dietary interventions (Tamura et al., 2009). This evidence concerns the gene ELOVL7 and Familial prostate cancer.